Societal CDMO

Societal CDMO is a bilateral Contract Development and Manufacturing Organization (CDMO) with capabilities spanning from pre-IND development to the commercial production and packaging of a wide range of therapeutic dosage forms, primarily focusing on small molecules. With expertise in addressing complex manufacturing challenges, Societal CDMO provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, sterile filling/finishing, lyophilization, packaging, and logistics services to the global pharmaceutical market.On March 21, 2022, Recro Pharma, Inc. was renamed Societal CDMO, Inc.